NeuroPace Inc — Director's Dealing 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeuroPace Inc (NPCE)
CIK: 0001528287
Period of Report: 2022-03-03

Reporting Person: Morrell Martha (Chief Medical Officer)

Non-Derivative Transactions

Derivative Transactions

Footnotes

F1: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on March 3, 2023 and the remaining RSUs vest in twelve (12) equal quarterly installments thereafter.

F2: 25% of the shares subject to the option vest on March 3, 2023. The remaining shares subject to the option vest in thirty six (36) equal consecutive monthly installments thereafter. The option is early exercisable.